Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-05

Clinical Trial Update: The Use of Methylsulfonylmethane (MSM) in the Treatment of Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 trial investigating methylsulfonylmethane (MSM) for low back pain has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Methylsulfonylmethane (Methylsulfonylmethane)

Snippet

Sponsor: Mike O'Callaghan Military Hospital | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2024-04-05